Actively Recruiting

Phase Not Applicable
All Genders
NCT05192980

SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours

Led by Institut Curie · Updated on 2025-07-22

600

Participants Needed

38

Research Sites

782 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The SIOPEN BIOPORTAL is a prospective non-therapeutic multi-centre international study aimed at developing an international Registry linked to a Virtual Biobank for all the patients with peripheral neuroblastic tumor within countries of the SIOPEN network. The overall aim of this study is to provide a GDPR-compliant framework to collect basic clinical annotations, biological and genetic features and information about the location on biospecimens for all the patients with a peripheral neuroblastic tumor including neuroblastoma, ganglioneuroblastoma and ganglioneuroma in the SIOPEN network. This study will support data and sample management and intensify cross-borders data and sample sharing fostering translational and clinical research. The post-hoc hypothesis formulated based on the data generated in this study will be used as statistical basis for future precision medicine programs based on improved biological characterization, patient stratification and therapeutic management.

CONDITIONS

Official Title

SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with peripheral neuroblastic tumors including ganglioneuroma, ganglioneuroblastoma, or neuroblastoma
  • At initial diagnosis of neuroblastic tumor or at relapse/progression if not yet registered
  • Written informed consent from patient or from parents/legal representatives with assent from child, adolescent, or young adult
Not Eligible

You will not qualify if you...

  • Adult patients diagnosed with olfactory neuroblastoma
  • Patients diagnosed with central nervous system neuroblastoma as per WHO classification

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 38 locations

1

Fakultni nemocnice v Motole

Prague, Czechia, 150 06

Actively Recruiting

2

CHU Amiens

Amiens, France, 80054

Actively Recruiting

3

Chu Angers

Angers, France, 49033

Actively Recruiting

4

Hôpital Jean Minjoz

Besançon, France, 25030

Actively Recruiting

5

Hôpital des enfants

Bordeaux, France, 33076

Actively Recruiting

6

Chru Brest

Brest, France, 29609

Actively Recruiting

7

CHU CAEN - Fédération de cancérologie - niveau 21

Caen, France, 14033

Actively Recruiting

8

CHU D'Estaing de CLERMONT FERRAND

Clermont-Ferrand, France, 63003

Actively Recruiting

9

DIJON Hôpital d'enfants

Dijon, France, 21079

Actively Recruiting

10

Chu Grenoble

Grenoble, France, 38045

Actively Recruiting

11

Centre Oscar Lambret

Lille, France, 59020

Actively Recruiting

12

Centre Léon Bérard

Lyon, France, 69373

Actively Recruiting

13

Hôpital d'Enfants de la Timone

Marseille, France, 13385

Actively Recruiting

14

Hôpital Arnaud de Villeneuve

Montpellier, France, 34295

Actively Recruiting

15

Chr Nantes

Nantes, France, 44093

Actively Recruiting

16

CHU NICE

Nice, France, 06202

Actively Recruiting

17

Institut Curie

Paris, France, 750248

Actively Recruiting

18

Hôpital Armand Trousseau

Paris, France, 75571

Actively Recruiting

19

Hôpital Jean Bernard

Poitiers, France, 86021

Not Yet Recruiting

20

Chu Reims

Reims, France, 51092

Actively Recruiting

21

Chu Hopital Sud

Rennes, France, 35056

Actively Recruiting

22

Hôpital Charles NICOLLE

Rouen, France, 76031

Actively Recruiting

23

Hôpital Nord

Saint-Etienne, France, 42055

Not Yet Recruiting

24

Hôpital Hautepierre-CHU Strasbourg

Strasbourg, France, 67098

Actively Recruiting

25

Hôpital des Enfants

Toulouse, France, 70034

Actively Recruiting

26

Hôpital Clocheville

Tours, France, 37044

Not Yet Recruiting

27

CHU NANCY- Hôpital d'Enfants

Vandœuvre-lès-Nancy, France, 54500

Actively Recruiting

28

Institut Gustave Roussy

Villejuif, France, 94800

Actively Recruiting

29

Oslo Universitetssykehus

Oslo, Norway, 0424

Actively Recruiting

30

Kantonsspital Aarau AG

Aarau, Switzerland, 5001

Actively Recruiting

31

Universitäts-Kinderspital beider Basel UKBB

Basel, Switzerland, 4056

Actively Recruiting

32

Ospedale San Giovanni

Bellinzona, Switzerland, 6500

Actively Recruiting

33

Inselspital Bern

Bern, Switzerland, 3010

Actively Recruiting

34

HUG Hôpitaux Universitaires Genève

Geneva, Switzerland, 1205

Actively Recruiting

35

CHUV, Centre hospitalier universitaire vaudois

Lausanne, Switzerland, 1011

Actively Recruiting

36

Kinderspital Zentralschweiz, Luzern

Lucerne, Switzerland, 6000

Actively Recruiting

37

Ostschweizer Kinderspital

Sankt Gallen, Switzerland, 9006

Actively Recruiting

38

Universitäts-Kinderspital Zürich

Zurich, Switzerland, 8091

Actively Recruiting

Loading map...

Research Team

G

Gudrun Schleiermacher, MD,PhD

CONTACT

K

Kamel BOURZAH, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here